Table 1.
Demographic profile and baseline characteristics of participants.
| Statistic | AZD1222 |
MVC-COV1901 |
Total |
p-value |
|---|---|---|---|---|
| N = 510 | N = 520 | N = 1030 | ||
| Age (years) | ||||
| Mean (SD) | 32.2 (11.70) | 32.1 (12.12) | 32.1 (11.91) | 0.8929 |
| Median | 29.0 (16.0) | 28.0 (16.0) | 29.0 (16.0) | |
| Min, Max (Range) | 18.0–71.0 (53) | 18.0–91.0 (73) | 18.0–91.0 (73) | |
| Gender (n/%) | ||||
| Male | 315 (61.8) | 304 (58.5) | 619 (60.1) | 0.279 |
| Female | 195 (38.2) | 216 (41.5) | 411 (39.9) | |
| Ethnicity (n/%) | ||||
| Latinx or Hispanic | 501 (98.2) | 509 (97.9) | 1010 (98.1) | 1 |
| White or Caucasian | 8 (1.6) | 9 (1.7) | 17 (1.7) | |
| Asian | 1 (0.2) | 2 (0.4) | 3 (0.3) | |
| BMI (kg/m2) | ||||
| Mean (SD) | 27.6 (5.90) | 27.3 (6.33) | 27.5 (6.11) | 0.432 |
| Median | 26.4 (7.7) | 26.2 (7.4) | 26.3 (7.6) | |
| Min, Max (Range) | 17.0–54.7 | 14.9–60.1 | 14.9–60.1 | |
| Comorbidity | ||||
| without | 336 (65.9) | 330 (63.5) | 666(64.7) | 0.416 |
| Any | 174 (34.1) | 190 (36.5) | 364 (35.3) | |
| Arrhythmia | 1 (0.2) | 1 (0.2) | 2 (0.2) | |
| Arterial Hypertension | 35 (6.9) | 25 (4.8) | 60 (5.8) | |
| Asthma | 8 (1.6) | 17 (3.3) | 25 (3.4) | |
| Cancer | 2 (0.4) | 1 (0.2) | 3 (0.3) | |
| Chronic Obstruction Pulmonary Disease (COPD) | 0 | 4 (0.8) | 4 (0.4) | |
| Diabetes | 12 (2.4) | 11 (2.1) | 23 (2.2) | |
| History of drug allergy | 20 (3.9) | 13 (2.5) | 33 (3.2) | |
| Kidney Disease | 0 | 4 (0.8) | 4 (0.4) | |
| Liver disease | 1 (0.2) | 3 (0.6) | 4 (0.4) | |
| Obesity | 106 (20.8) | 108 (20.8) | 214 (20.8) | |